0,924  0,002  Muscle relaxant
0,914  0,002  Skeletal muscle relaxant
0,888  0,002  Pneumotoxic
0,831  0,003  Cardiodepressant
0,823  0,005  Antileukemic
0,819  0,004  Spasmolytic
0,781  0,005  Prostate cancer treatment
0,737  0,004  Histamine release inhibitor
0,738  0,024  Apoptosis agonist
0,704  0,020  Antineoplastic (breast cancer)
0,682  0,020  Antineoplastic (lung cancer)
0,670  0,009  Vasodilator, peripheral
0,620  0,005  P-glycoprotein inhibitor
0,599  0,004  Sigma receptor agonist
0,598  0,005  5 Hydroxytryptamine antagonist
0,607  0,014  5 Hydroxytryptamine release stimulant
0,587  0,004  Acetylcholine nicotinic antagonist
0,563  0,005  Anesthetic general
0,571  0,035  Transcription factor NF kappa B inhibitor
0,521  0,005  Dopamine antagonist
0,534  0,017  Hepatic disorders treatment
0,511  0,008  Antineoplastic (liver cancer)
0,516  0,018  Caspase 3 stimulant
0,519  0,043  Alzheimer's disease treatment
0,482  0,012  Sedative
0,489  0,024  Radioprotector
0,469  0,004  Dopamine D1 antagonist
0,470  0,005  Dopamine D2 antagonist
0,454  0,004  Dopamine agonist
0,443  0,004  Dopamine D2 agonist
0,456  0,019  Tumour necrosis factor alpha release inhibitor
0,453  0,016  Vasodilator
0,435  0,003  Calcium antagonist
0,429  0,004  Neuronal nicotinic receptor antagonist
0,425  0,006  Acetylcholine antagonist
0,423  0,007  Cholinergic antagonist
0,435  0,022  Antipyretic
0,416  0,005  Alpha 2 adrenoreceptor antagonist
0,447  0,036  Antidepressant
0,437  0,030  Antineoplastic (pancreatic cancer)
0,422  0,018  Antineoplastic enhancer
0,444  0,042  CYP2C19 inhibitor
0,399  0,013  Antiseptic
0,395  0,009  Alpha adrenoreceptor antagonist
0,392  0,007  5 Hydroxytryptamine 1 antagonist
0,403  0,023  Antimitotic
0,426  0,048  Antineoplastic (colorectal cancer)
0,383  0,012  DNA methylase inhibitor
0,380  0,013  Antineoplastic (squamous cell carcinoma)
0,409  0,043  Respiratory analeptic
0,428  0,064  Antiparkinsonian
0,365  0,003  Nicotinic receptor alpha3 subunit antagonist
0,406  0,049  Antineoplastic (colon cancer)
0,362  0,007  5 Hydroxytryptamine 1A antagonist
0,402  0,051  Mood disorders treatment
0,390  0,055  Antiprotozoal (Plasmodium)
0,345  0,020  Hepatoprotectant
0,364  0,040  Hypoxia-inducible factor 1 alpha inhibitor
0,388  0,066  CYP3A4 substrate
0,342  0,021  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,388  0,068  Antineoplastic (myeloid leukemia)
0,351  0,031  Psychostimulant
0,333  0,016  Tubulin antagonist
0,362  0,048  Cardioprotectant
0,320  0,019  5 Hydroxytryptamine 1E antagonist
0,356  0,055  CYP2D6 substrate
0,323  0,030  Antiparkinsonian, rigidity relieving
0,345  0,054  Antineoplastic (brain cancer)
0,346  0,055  Nootropic
0,298  0,012  Toxic, respiratory center
0,339  0,054  CYP1A2 substrate
0,285  0,012  Alpha 1 adrenoreceptor antagonist
0,286  0,014  Antiadrenergic
0,387  0,119  Caspase 9 stimulant
0,272  0,008  Alpha 2c adrenoreceptor antagonist
0,276  0,015  Adrenaline antagonist
0,270  0,012  Alpha 2b adrenoreceptor antagonist
0,296  0,039  Antiarrhythmic
0,259  0,006  Opioid kappa receptor antagonist
0,338  0,086  CYP2C9 substrate
0,255  0,004  Nicotinic receptor alpha7 subunit antagonist
0,253  0,008  Polo-like kinase-4 inhibitor
0,313  0,069  Antineoplastic (ovarian cancer)
0,258  0,014  Butyrylcholinesterase inhibitor
0,307  0,069  Antipsychotic
0,259  0,027  Cholinergic
0,305  0,072  Analeptic
0,278  0,046  Tyrosine 3 hydroxylase inhibitor
0,240  0,010  Alpha 2a adrenoreceptor antagonist
0,239  0,013  Alpha 1a adrenoreceptor antagonist
0,235  0,010  Breast cancer-resistant protein inhibitor
0,241  0,023  5 Hydroxytryptamine 2 antagonist
0,224  0,012  Constipation treatment
0,220  0,009  Antineoplastic alkaloid
0,216  0,005  Dopamine D5 antagonist
0,222  0,012  5 Hydroxytryptamine agonist
0,239  0,033  Antineoplastic (carcinoma)
0,229  0,025  Acetylcholinesterase inhibitor
0,283  0,081  CYP2D6 inhibitor
0,210  0,011  5 Hydroxytryptamine 7 antagonist
0,218  0,021  Antitussive
0,214  0,018  5 Hydroxytryptamine 2A antagonist
0,198  0,004  Antibiotic Glycopeptide-like
0,208  0,017  Antiprotozoal (Amoeba)
0,199  0,008  Electron transport complex I inhibitor
0,269  0,084  Antineoplastic (melanoma)
0,230  0,046  Male reproductive disfunction treatment
0,187  0,004  Potassium channel small-conductance Ca-activated blocker
0,304  0,121  Antiprotozoal
0,220  0,038  LDLR expression enhancer
0,204  0,026  5 Hydroxytryptamine 2B antagonist
0,188  0,010  Analgesic, opioid
0,251  0,079  DNA damaging
0,203  0,039  Erectile dysfunction treatment
0,179  0,018  Opioid antagonist
0,169  0,009  Histamine N-methyltransferase inhibitor
0,173  0,013  Dopamine D3 antagonist
0,244  0,086  UGT1A9 substrate
0,212  0,063  Nitric oxide antagonist
0,206  0,059  UGT2B7 substrate
0,160  0,015  Opioid mu receptor antagonist
0,149  0,014  5 Hydroxytryptamine 1 agonist
0,143  0,011  Calcium channel L-type blocker
0,181  0,050  UGT2B9 substrate
0,182  0,053  Antiviral (Influenza A)
0,246  0,119  CYP3A4 inhibitor
0,145  0,018  Phosphodiesterase I inhibitor
0,177  0,055  Uterine stimulant
0,125  0,003  Prolactin release inhibitor
0,128  0,007  Opioid kappa receptor agonist
0,138  0,017  Antihypermotility
0,249  0,129  Apoptosis antagonist
0,131  0,012  5 Hydroxytryptamine 1A agonist
0,135  0,019  5 Hydroxytryptamine 1F antagonist
0,139  0,027  Prolactin inhibitor
0,155  0,044  Alkylator
0,273  0,163  Analgesic
0,247  0,137  Vasodilator, coronary
0,123  0,014  Dopamine uptake inhibitor
0,151  0,043  Acetylcholine muscarinic antagonist
0,117  0,010  Opioid mu receptor agonist
0,164  0,058  Antinephritic
0,113  0,008  5 Hydroxytryptamine 2 agonist
0,201  0,097  Free radical scavenger
0,202  0,099  Antineoplastic (glioma)
0,122  0,019  Phosphodiesterase 11A inhibitor
0,122  0,019  Phosphodiesterase XI inhibitor
0,223  0,121  Anxiolytic
0,221  0,121  Antineoplastic (multiple myeloma)
0,148  0,048  Antismoking
0,110  0,012  Opioid agonist
0,106  0,008  Potassium channel (Ca-activated) blocker
0,154  0,060  Anesthetic
0,119  0,026  Opioid delta receptor antagonist
0,159  0,067  Acetylcholine M1 receptor antagonist
0,134  0,044  Antiviral (Influenza B)
0,116  0,027  Restless leg syndrome treatment
0,115  0,026  Tocolytic
0,183  0,095  Neurotrophic factor enhancer
0,101  0,014  5 Hydroxytryptamine 6 antagonist
0,095  0,009  Nicotinic receptor alpha4 subunit antagonist
0,179  0,094  VEGF expression inhibitor
0,108  0,025  Nicotinic alpha4beta2 receptor antagonist
0,103  0,022  Narcotic antagonist
0,112  0,031  Alpha 1b adrenoreceptor antagonist
0,104  0,025  Dopamine D4 antagonist
0,181  0,102  Dependence treatment
0,147  0,069  Antiparkinsonian, tremor relieving
0,159  0,082  Mutagenic
0,091  0,018  Sigma receptor antagonist
0,081  0,009  Ryanodine receptor antagonist
0,199  0,127  Antineoplastic (sarcoma)
0,084  0,014  Phosphodiesterase 1A inhibitor
0,152  0,083  Cystic fibrosis treatment
0,101  0,033  Antiviral (Hepatitis A)
0,094  0,026  5 Hydroxytryptamine 1B antagonist
0,247  0,179  Antibacterial
0,110  0,044  Uric acid excretion stimulant
0,127  0,062  Topoisomerase II inhibitor
0,070  0,004  Liver X receptor alpha antagonist
0,165  0,100  Antimigraine
0,096  0,032  Acetylcholine M4 receptor antagonist
0,085  0,023  5 Hydroxytryptamine 2A agonist
0,092  0,031  Alpha adrenoreceptor agonist
0,196  0,136  CYP2C19 substrate
0,231  0,174  Antineoplastic (small cell lung cancer)
0,063  0,007  Liver X receptor antagonist
0,160  0,107  UGT1A1 substrate
0,142  0,090  UGT1A3 substrate
0,069  0,018  5 Hydroxytryptamine 4 antagonist
0,129  0,078  Calcium channel blocker
0,069  0,020  5 Hydroxytryptamine 7 agonist
0,082  0,033  5 Hydroxytryptamine uptake inhibitor
0,178  0,133  Antioxidant
0,199  0,154  5 Hydroxytryptamine uptake stimulant
0,070  0,026  5 Hydroxytryptamine 5 antagonist
0,154  0,110  Antiviral (Influenza)
0,066  0,022  Dopamine transporter inhibitor
0,082  0,039  Phosphodiesterase V inhibitor
0,092  0,051  5 Hydroxytryptamine 2C antagonist
0,180  0,139  Cardiotonic
0,069  0,028  Alpha 1 adrenoreceptor agonist
0,071  0,030  5 Hydroxytryptamine 5A antagonist
0,089  0,049  ALK inhibitor
0,066  0,027  Alpha tubulin antagonist
0,043  0,005  Dopamine D1 agonist
0,070  0,032  Alpha 2 adrenoreceptor agonist
0,073  0,038  Glutamate (mGluR7) antagonist
0,077  0,042  Phosphodiesterase 5A inhibitor
0,167  0,133  Antineoplastic (non-small cell lung cancer)
0,071  0,037  5 Hydroxytryptamine 1D antagonist
0,055  0,024  5 Hydroxytryptamine 2C agonist
0,099  0,068  Nav1.1 sodium channel blocker
0,046  0,016  Opioid delta receptor agonist
0,162  0,133  Cyclic AMP phosphodiesterase inhibitor
0,098  0,069  Estrogen receptor beta antagonist
0,127  0,098  Genotoxic
0,137  0,109  Carcinogenic
0,038  0,010  Dopamine autoreceptor agonist
0,068  0,041  Uterine relaxant
0,142  0,114  Amyloid beta aggregation inhibitor
0,117  0,091  Cocaine dependence treatment
0,056  0,032  5 Hydroxytryptamine 1B agonist
0,212  0,188  Cognition disorders treatment
0,097  0,075  Toll-Like receptor 4 antagonist
0,112  0,094  Antiviral (Papilloma)
0,137  0,122  Platelet adhesion inhibitor
0,169  0,155  Antihypotensive
0,052  0,040  Nicotinic alpha3beta2 receptor antagonist
0,043  0,031  Liver X receptor agonist
0,131  0,122  Carcinogenic, group 1
0,211  0,202  15-Lipoxygenase inhibitor
0,113  0,106  Activin receptor-like kinase 2 inhibitor
0,036  0,030  Vesicle monoamine transporter inhibitor
0,047  0,042  Factor III inhibitor
0,052  0,047  Alpha 1d adrenoreceptor antagonist
0,044  0,041  Phosphodiesterase 6C inhibitor
0,148  0,146  Antineoplastic (cervical cancer)
0,014  0,013  NMDA receptor phencyclidine site antagonist
0,048  0,047  Postmenopausal disorders treatment
0,100  0,099  Estrogen antagonist
0,069  0,069  Estrogen receptor alpha antagonist

